drugset / Trial / NCT00812773

Study to Evaluate GSK2190915 in Subjects With Mild Asthma

NCT00812773

Phase 2 Completed 17 enrolled GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

This study will evaluate the safety and effect of repeat oral doses of GSK2190915 on lung function in mild asthmatics using a number of clinical and biological markers of efficacy.

Timeline

Start
2008-12
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject FIBOFLAPON Small molecule Oral

Indications